Univar Solutions Inc.

Q2 2021 Earnings Conference Call

8/3/2021

spk01: Good morning, ladies and gentlemen, and welcome to Univar Solutions' second quarter 2021 earnings conference call. My name is Carol, and I will be your host operator on this call. Currently, all participants are in a listen-only mode. After the presentation, we will conduct a question-and-answer session. Instructions will be provided at that time. If at any time during the conference call you need to reach an operator, please press star followed by zero. I will now turn the meeting over to your host for today's call, Heather Koss, Vice President of Investor Relations and Communications at Univar Solutions. Heather, please go ahead.
spk00: Thank you, and good morning. Welcome to Univar Solutions' second quarter earnings call and webcast. Joining our call today are David Jukes, President and Chief Executive Officer, and Nick Alexos, Executive Vice President and Chief Financial Officer. Last night, we released our financial results for the second quarter ended June 30th, 2021, and posted to our corporate website at univarsolutions.com a supplemental slide presentation to go with today's call. The slide presentation should be viewed along with the earnings release, which has also been posted on our website. During this call, as summarized on slide two, we will refer to certain non-GAAP financial measures for which you can find the reconciliation to the most directly comparable GAAP financial measures in our earnings release and the supplemental slide presentation. As referenced on slide two, we will make statements about our estimates, projections, outlook, forecast, and our expectations for the future. All such statements are forward-looking, and while they reflect our current estimates, they involve risks and uncertainties and are not guaranteed of future performance. Please see our SEC filings for a more detailed summary of the risks and uncertainties inherent in our business and our expectations for the future. On slide three, you will see the agenda for the call. David will start with second quarter highlights and end market trends. Nick will walk through our financial update, and then David will close with progress on our business strategy. Following that, we will take your questions. With that, I'll now turn the call over to David for his opening remarks.
spk05: Thank you, Heather, and good morning, good afternoon, and good evening to everyone, and thanks for joining our call. I'm pleased to report such a strong financial performance against a backdrop of good customer demand but constrained supply and disrupted supply chains. We believe the performance is a testament to our operating digital infrastructure as well as our outstanding team of dedicated colleagues. Their ability to identify trends, grow our supplier and customer relationships, as well as build on investments in both technology and our growing global specialty and market verticals has positioned as well to deliver for our customers and supplier partners and achieve another strong quarter of results. As we continue to execute our strategy and focus on growing together, we're building momentum and believe our singular focus on strong operational execution is paying off as we advance our strategic priorities and complete our integration activities. Key highlights from the quarter are We delivered strong Q2 adjusted EBITDA of $197.5 million, with liquidity of $882 million at quarter end, inclusive of $279 million of debt pay down in the quarter. Our headline sales were up versus prior year, as we continued to deliver growth in our core business, even with the effects of our divestiture program and exit from our Canadian ag distribution business. We improved our sales performance with positive win-loss ratios in all regions, and then in the quarter with much improved retention levels for new customers. Our SAP migration work has just been completed in Canada, with now only Mexico outstanding. We remain on track to deliver on our commitment of $120 million of net synergies from the Nexio integrations. Our digital investments are delivering real benefit, with approximately 40% of our U.S. customers now registered on our e-commerce channels and able to utilize 24-7 self-service capabilities. Additionally, approximately 21% of U.S. customers are utilizing our digital tracking capabilities, and the amount of orders placed through our shop channel increased by more than 50% quarter of a quarter. and we strengthened our position in our global specialty and market verticals with more new supplier authorizations in the quarter. We saw increasing business activity globally, with sales improving throughout the quarter. Once again, we were able to provide existing customers with security of supply as demand outpaced the supply of products, containers, and transport, as well as support the needs of new customers who've been let down elsewhere. The second quarter of 2021 experienced the strongest year-over-year growth and overall financial metrics in the recent history of Univar Solutions. Prior year comparisons were aided by the strong economic recovery and pricing reflecting demand and ongoing supply disruptions from the winter storms in Texas. We believe our global network and strong supplier partnerships provided us with a distinct strategic advantage over much of our competition, as we were able to leverage the capabilities of a single ERP in the USA to ensure we optimized available supply throughout the network. Our industrial solutions business saw strength in construction and automotive-related chemistries, with strong demand in many of the critical products for these markets. Food and personal care both experience double-digit growth, with consumer demand accelerating as vaccination programs are proving effective in much of the world. Unforeseen shortages in certain key ingredients have strengthened our value proposition within both industries, as we believe our ability to deliver bespoke formulations and strong supplier partnerships have positioned us to provide a differentiated value to customers. Our general industrial business has seen strong demand across the various markets, but in particular, chemical manufacturing, machinery, and paper. Our water treatment portfolio has been especially essential for the drought-stricken western United States. Our extensive organic chemistry portfolio has supported growth in these segments, while the ability to leverage our scale enabled us to provide our customers with secure supply. Although now a much smaller part of our business, oil and gas-related demand returns to double-digit growth compared to the prior year, with oil prices currently at pre-COVID levels and weekly oil and gas rig counts steadily increasing. Production chemistries in particular saw strong demand. Our services business was strong in the quarter, largely due to automotive and airline sectors where we managed chemical waste streams and related recycling programs. For 2021, we still expect levered gross profit growth at a rate better than industrial production indices. And with the third quarter starting strongly, we're expecting adjusted EBITDA guidance of $175 to $185 million for the third quarter. and are raising our adjusted EBITDA guidance range for the full year to $705 to $725 million, with net free cash flow conversions above 40%, which Nick will expand upon shortly. Beyond 2021, we believe the completion of the integration activities, the SAP migration, and the actions we are taking to streamline our business have further positioned us for sustainable success. We have the right people, products, tools, and strategy that we expect will deliver the innovative solutions our customers and suppliers value and position us to deliver shareholder value. Now, let me turn the call over to Nick. He will walk you through our second quarter results and our outlook. Then I will share some brief closing thoughts.
spk04: Thank you, David. Good morning and hello to all. I am pleased to share Universal Solutions Q2 financial results update you on our business activities, and provide our outlook for the rest of the year. Sales were up 19.2 percent on a reported basis and 15.4 percent on a constant currency basis. Excluding results of the exited Canadian agricultural businesses and distriple from the prior year financials, we estimate net sales to be up 30.5 percent and up 26.4 percent on a constant currency basis. This growth is primarily due to the impact of chemical price inflation and higher industrial demand. Gross profit exclusive depreciation was higher by 23.2% to $602.5 million and a 19.3% growth on a constant currency basis. Our gross margin increased by 90 basis points to 25.2% driven primarily by the Canadian agricultural distribution exit. Excluding the ag businesses and Disreport, margins were down 60 basis points as a positive impact of this year's chemical price inflation was offset by the absence of prior year's favorable product mix benefiting from certain essential end markets of $20 million. Second quarter adjusted EBITDA of $197.5 million was up by 21% and 16.2% on a constant currency basis, compared to the prior year. Adjusting for the exited businesses, growth was 22.2% on a constant currency basis. The increase was primarily driven by chemical price inflation, higher industrial demand, and the realization of nexio net synergies partially offset by higher WSNA. The WSNA increase was due to higher variable compensation driven by the outperformance of the businesses and reinvestments in operating costs versus the temporary reductions implemented last year. Despite the higher WS&A, EBITDA margins did improve by 10 basis points. Moving on to slide seven, Q2 GAAP net income was 153.2 million, or 90 cents per share, compared to 1.8 million in the prior year. The increase was primarily due to higher gross profit a gain on the sale of our distrable business, and the effect of the expiration of the warrant related to the February 2019 Nexio Solutions acquisition. These were partially offset by the higher WS&A, which included the variable compensation and pension-related expenses. For our detailed schedules in the appendix, adjusted earnings per diluted share were $0.57 in the quarter, an increase from $0.33 in the prior year second quarter. Operating cash flow had a higher use of cash versus the prior year period, primarily due to networking capital use driven by the strong acceleration in Q2 sales this year, sequentially, quarter over quarter of about 11%. versus the sequential decline in the prior year, which, as we all know, was impacted by the effects of the COVID-19 pandemic. This was partially offset by higher net income during the quarter. We're able to maintain ample liquidity of $882 million, inclusive of $207 million in cash, and the availability under our asset-based credit lines. We expect levels of working capital and cash flow through the rest of the year to follow our traditional seasonal trends. During the quarter, we refinanced $1.3 billion of term loans with a new $1 billion term loan net of debt with pay down of $279 million. As part of this refinancing, we extended the maturity of the term loan to 2028. and reduce the interest rate by 25 basis points, which will save approximately $2.5 million a year in interest expense. There is also an opportunity to further reduce the rate by 25 basis points if our leverage falls below 2.5 times, saving an additional $2.5 million per annum. Capital expenditures for the quarter were $23 million, and next-year integration-related expenses were on plan at $19 million. Our ROIC was 11.4% for the quarter, and leverage now stands at 3.2 times. On slide 8, we've aggregated the key metrics across our four reporting segments, and we provide details in the appendix. Sales across all geographies benefited from chemical price inflation and higher industrial and market demand. Sales were higher year over year in all the regions, except for Canada, which saw a reported decline due to the exit from our agricultural businesses. EMEA's reported sales were also negatively impacted by the district pool divestiture. Coast margins were lower in USA, EMEA, and Letham. USA saw strong demand in our LCD business, resulting in a change in margin for the quarter. EMEA and LATAM were impacted by the lower benefit from certain essential end markets in the prior year. In Canada, gross margins benefited from the agricultural distribution business exit as well as favorable mix. Adjusted EBITDA margins expanded in USA and Canada and declined in EMEA and LATAM. In USA, lower gross margins were mitigated by better cost management and resulting operating leverage positively impacted EBITDA margins. EBITDA margins for other segments were driven by the relative gross margins. Overall, the increase in sales was higher than the increase in WS&A, except for Canada, due to the ag business exits. Moving to slide nine, we remained confident in our ability to execute on our strategies in 2021. As we have highlighted before, our 2020 adjusted EBITDA of $636 million included approximately $20 million of earnings from the Canadian Agriculture Services business, which we exited in Q4, and DistriPol, which closed on April 1st this year. We also had a benefit of $35 million from essential end market demand in 2020, which we didn't expect to recur at that level in 2021. For our 2021 outlook, we continue to expect increased market share growth in the year, and we anticipate our business to grow at a higher rate than our previous expectations and above the general economic consensus of 6 plus percent U.S. industrial production growth rate, which we are using as a benchmark. For the rest of the year, we expect to see a trend towards a normalization of chemical prices and a continuing broad reopening of North American and European economies. These dynamics, along with our solid execution and the continuation of better product mix through robust customer demand in our focused industries, will drive good results. Accounting for all these factors, as well as future performance, we are increasing our expected adjusted EBITDA guidance to $705 million to $725 million for fiscal year 2021, $25 million higher at the midpoint from our prior full year guidance, and almost 12% higher from the midpoint of our initial guidance for the fiscal year 2021. Guidance for our Q3 2021 adjusted EBITDA is in the range of $175 to $185 million. As you would expect, we are closely tracking the market dynamics And we recognize that some of the current pricing levels may not be sustainable beyond the next few quarters. However, we believe a solid base for adjusted EBITDA of 690 to 700 million is our benchmark for growth into 2022. On slide 10, let's review some of the cashflow highlights of our 2021 outlook. Networking capital liquidation from exiting of the Canadian agriculture distribution business has resulted in net proceeds of $4 million as of Q2, with an additional $21 million expected to come through by early Q3 of 2021. These amounts are net of related payables and are in addition to the $52 million received in Q4 of 2020. Our plan is to continue to target net working capital in line with our guidance of 13 to 14% of annualized quarterly sales. Planned sales in our current guidance are expected to result in only a slight use of cash from working capital for the full year, implying good cash flow in the second half. Cash use of other expenses and timing of year-end accruals is expected to be up to $35 million. Final next-year integration expenses, which are not included in our adjusted EBITDA forecast, are expected to be up to $70 million for the year. We are planning for $125 million worth of capital expenditures for the year in line with our initiatives to invest in high ROI projects to increase competitiveness. We recognize that with COVID, there have been some delays in the year that they spend, but during the second half, we hope to catch up and thus avoid a significant carryover into 2022. Consequently, we are targeting net free cash flow of 280 to 300 million for 2021, resulting in a net free cash flow conversion above 40%. Net leverage, excluding further divestment proceeds, is now expected to be 2.7 times or lower by year end 2021 versus the prior guidance of 2.8 and clearly ahead of our S22 target of 3.0. We expect to have ample cash and line of credit liquidity throughout the year, even after some additional permanent debt reductions. During the three months ended June 30th, 2021, a portion of the expiring warrants relating to the next CEO acquisition were exercised at a price of $27.80, resulting in the issuance of approximately 1 million of newly issued shares of common stock. Given this, we expect shares outstanding for 2021 to be in the range of 171.5 million to 172 million. In conclusion, we are very pleased with our results for the second quarter and remain optimistic about our outlook for the full year and beyond. Our teams, every day, execute very well in challenging environments, and I'm excited to see the continued progress we are making against our S22 and growth objectives. We are continuing to implement our plans to achieve a run rate adjusted EBITDA margin of 9% by the end of 2022, and we intend to provide more details on the 2021 through 2023 margin bridge at our upcoming analyst day. David.
spk05: Thank you, Nick. As you can see, we're making solid progress on our business strategy, and the strength and capability of our sales force remains a key driver of business improvement as we leverage our advantage network of technical and regional sellers in combination with our digital platforms. This is evidenced by our positive win-loss ratio in all four regions and new customer retention. The expansion of a consistent, technically differentiated approach to customers through the globalization of our specialty end markets and the consumer and industrial solutions verticals is delivering growth. Our expertise and committed investments in these verticals is being rewarded with new or expanded supplier partnerships, and with roughly half of those announced in the quarter being wins from existing distribution channels. This past weekend, we successfully migrated our Canadian business onto our SAP platform, and the move in Mexico is scheduled for November. This will complete the Nexio integration activities from which we delivered $8 million of net synergies during the quarter and expect to achieve our net synergy goal of $20 to $25 million this year and $120 million in total by Q1 of 2022. Moving on to S22. As mentioned last quarter, we sold the Distropole Plastics business in Emea on April 1st, and later in the quarter, we divested additional assets in the region. To date, we have realized approximately $186 million in gross proceeds from disposals. In Q3, we expect to deliver $6 million from further asset sales in Europe and expect to realize most of our targeted total net pre-tax proceeds. As Nick detailed, our expected strong cash flow and divestiture proceeds enable us to meet and beat the first of our S22 objectives and reduce our net leverage to below three times by year-end, actually to 2.7 times or lower Our commitment to being a digital leader continues as we accelerate our omni-channel approach. We now have a single, integrated digital commerce platform at universolutions.com, enabling customers to search, select, source, and self-serve whatever the time of day or night they choose. This investment is delivering results, and we continue to enhance its capabilities based on customer feedback. We're now providing users with real-time pricing without log-in Quarter of a quarter, sequentially, we've seen a 42% increase in document downloads, a 58% increase in orders through Shop, and a 12% increase in orders placed through ChemCentral, our no-frills channel, which also launched in France and Brazil in the quarter. Our digital vision is clear, and we're beginning to realize the benefits of our capabilities as a source of continued and sustainable competitive advantages. Putting the customer at the center of all we do, we've established our global voice of customer process, leveraging our Net Promoter Score, or NPS. As of June, our overall score is good, despite challenging tight supply chain conditions impacting our results. Regular reviews have been instituted to ensure we are listening to customers' feedback and adjusting or developing our processes based on what they truly value. This involves reviews from me right down through the organization as we work to build out the effortless experience we believe our customers deserve. To help with this, and using advanced analytics capabilities, we have progressed the development of a customer 360 model that provides us with a single view of customer performance, including NPS and customer-centric metrics all along the customer journey. This model is designed to provide predictive insights that we believe will aid in prioritizing improvements towards an effortless experience for customers. Altogether, our digital investments and customer-centric approach is designed to maximize the effectiveness and scale of our operations, turning data into a strategic asset and making it easier for customers and suppliers to do business with us. we released our latest annual sustainability report in June, which is our 12th edition. The 2020 sustainability report reflects the company's commitment to grow today, tomorrow, together, through both our commercial strategic priorities and sustainability approach. While showing we are on track to meet or exceed our 2021 sustainability goals, which were set back in 2017, We provide a comprehensive view into our ambitious sustainability goals to 2025 and beyond with a net zero ambition by 2050. A few other ESG highlights for the first half of the year include we announced new supplier authorizations for a number of more environmentally friendly solutions. We continue to invest in projects to reduce our carbon footprint in line with our net zero commitments. We continue to give back to our communities as well as support STEM programs globally, like our sponsorship and active involvement in the You Be the Chemist program organized by the Chemical Education Foundation in the U.S. We continue to put safety first, which is evidenced by our world-class safety record. And we introduced our new supplier code of conduct to support sustainability throughout the value chain. ESG is a priority for us as it touches each of our core values and aligns with our vision to redefine distribution and be the most valued chemical and ingredient distributor on the planet. As well, it's been a better steward of Earth's resources. Understanding is our home, our responsibility. Before we come to your questions and to summarize, We delivered strong Q2 adjusted EBITDA while realizing our purpose to help keep our communities healthy, fed, clean, and safe, even during challenging times. We have again raised our four-year adjusted EBITDA guidance, this time to 705.
spk01: Thank you. At this time, if you would like to ask a question, simply press star, then the number one on your telephone keypad. If you would like to withdraw your question, press the pound key. Please limit yourself to one question and one follow-up. Please hold while we compile the Q&A roster. Your first question comes from the line of Kevin McCarthy from Vertical Research Partners. Kevin, your line is open.
spk06: Good morning. This is Corey on for Kevin. How are you?
spk01: Good morning, Corey.
spk06: Morning. So you mentioned taking market share. Can you provide a little bit more detail maybe by geography or by end market and how you are accomplishing this market share gain?
spk05: Sure. I think that really we're looking right across all our markets. We have really good capability in those specialty consumer solutions and industrial solutions, verticals, and new authorizations are helping us drive share as well as continue to invest in our technical capabilities and our technical sales organization. In the chemical distribution business, we're seeing good growth in the U.S. and in EMEA. I think particularly we have products, we have containers, we have transport, so we are a more reliable source of product when others can't deliver. So I think we're finding it's quite a good environment for us to win with customers. That's why we're so focused also then on our MPS to make sure that we are really supporting customers. Our win-loss ratio is improving in all areas, in all regions. So I think really what we're seeing is our business executing well and our strategy playing out.
spk06: Thank you for that. That's helpful. And if I may, your free cash flow guidance suggests maybe $200 million tailwind in the back half of the year. Can you walk through some of the assumptions underpinning that? Maybe what are your price assumptions?
spk05: Sure. Let me ask Nick to walk through that for you.
spk04: Yes. Hey, Corey. It's Nick. Good morning. As we mentioned in the script, we do expect some level of pricing to come down. in the second half of the year, and we are going into our seasonal lower quarters. So those factors do drive the breakdown of the working capital just driven off of the sales. And we also expect to improve some of our efficiencies on working capital, like many people collecting processes during the COVID environment have had some challenges. We still ended up relatively close to our 13% to 14% target. We were above that in the first half, but we expect to be below that getting to the second half. So the combination of the lower top line and the improved efficiencies in collections drive the working capital cash flow in the second half.
spk06: Thank you very much.
spk01: Your next question comes from the line of Laurent Faivre with Exane. Laurent, your line is open.
spk08: Good morning. David, when you talk about normalization into the second half, I'm wondering, are you purely referring to lower pricing and margins or are you also referring to some of the business volumes that you gain as you add the ability to supply where your customers or the newer customers, I guess, may go back to their original sources of supply?
spk05: Hey, Laurent. Good question. Thank you. I think what we're seeing, we're very, very confident about our sales approach and very confident about the service that we're providing customers right now. It is really thinking about pricing, thinking about pricing normalizing a little bit. So we expect some of the tailwinds we've had on margin, certainly from the first half, to taper off into the second half, although we still expect pricing to be strong, but we expect demand to be strong, and we're very confident in our ability to support customers.
spk08: Thank you. And as a follow-up question, You mentioned a lot that you are a head of target on teleworking. We've seen most of your peers be more active on M&A since the beginning of this year. I'm wondering, now that you are a lot closer to two and a half times, should we expect you to be more active on M&A or should we be expecting some shareholder returns or both?
spk05: Yeah, our capital allocation strategy, you know, I think, We've highlighted before our priority was to get our leverage down, and we're well on track to do that. And we see the opportunity for some good bolt-on acquisitions, both in the Americas as well as in other markets as well. So we have turned our attention to that already, and we have a program and a process to do that. I have to say nothing that's been sold recently. We've lamented on that at all. I think we've looked at many things. and turned away from many things. We're going to continue to be very disciplined around the businesses that we add to our portfolio. But our capital allocation strategy is to invest in high ROI capex to drive growth, some bolt on acquisitions, and then look at how we return capital to shareholders. And we'll share a lot more about this at the Investor Day later this year.
spk08: Thank you.
spk01: Your next question comes from the line of David Begleiter with Deutsche Bank. David, your line is open.
spk07: Hi, this is David Huang here for Dave. I guess you talked about you're expecting normal signal trends this year, while some of your suppliers and customers are expecting more muted seasonality this year. Can you just talk about how you think about seasonality for the second half And then on your guidance for Q3 and Q2, it looks like the drop from Q3 to Q2 is a little bit bigger, even assuming normal seasonality. Is that just a function of normalizing prices? Thanks.
spk05: Thanks, David. Look, I think Q3 to Q2 is seasonal. You've got a seasonal adjustment in there. We expect sales to be generally lower because of that seasonality trend, and we see that kind of normalization of margins coming back. But we do think, as I said earlier on, we see continued strong demand across all markets, and we're very confident in our ability to deliver and capture that demand.
spk07: Okay. And then just across your end markets, can you talk about where you're seeing the strongest growth and are there still any end markets that are below pre pandemic levels?
spk05: I think you have to look at micro markets, you know, rather than markets that are below pre-pandemic levels. So, you know, personal care, personal and beauty care is strong, although, you know, things like makeup, cosmetics is still a pre-pandemic level. It's not until people really start going back to work and getting out more will we see that pick up. But we're seeing good strength across all markets, as I think we highlighted in the prepared remarks. Thanks.
spk01: Your next question comes from the line of Michael McGinn with Wells Fargo. Michael, your line is open.
spk02: Hey, good morning, everybody. Hey, Michael. I may have missed this comment, but you said earlier in the call you were benchmarked, you raised the guidance, but you're benchmarking to 690 to 700. Is that correct? And what do you mean by that statement?
spk05: Yeah, I think that what we're saying is if we look at the puts and takes that are delivering this year, that if we look at the exceptional pricing, the exceptional margin, certainly particularly from Q1 into Q2, that will normalize out. And so I think a normalized run rate for this year would be a 6,9700 for us to base our growth on for next year.
spk04: And I would add, Michael, on that is the higher variable compensation, which we're also calling out, which has been a benefit, obviously, to all our colleagues, but is at a higher level than normal, which would be an offset going into next year versus the chemical price inflation benefit that we expect to taper down. So those two kind of net against each other. I mean, there are other puts and takes. Obviously, we had a little bit of a district poll pick up in the beginning of the year. That's not going to recur next year. So we're just calling out a base level that we think is a good growth platform going into next year.
spk02: Okay. So the back of the envelope math would suggest if I take the midpoint of that 695 and then maybe a blended EBITDA full year rate of 8.5%, that gets me to sales of $8.1 billion, which is down maybe about 7% from this year, given the pricing momentum you talked about. Is that the ballpark estimate you guys are looking at?
spk05: That is back of the envelope math. I'm not going to comment on back of the envelope math, and I'm not giving guidance for next year. We're looking at, I think we've given as much guidance as we possibly can do, or as much insight into our thinking as we possibly can do, to allow you to base the modeling, really. And I think we intend to grow better than industrial production. That's our intention. That's what we will do next year.
spk02: Got it. Um, and switching gears to, you know, um, I guess the guidance, a lot of you're already running essentially this quarter at a 9% EBITDA margin run rate in all your segments, XUS, and you just got the ERP implementation done there. So can you just walk us through what you see as the progression of EBITDA margins the next couple of quarters for that one segment for you guys?
spk04: Yeah, I mean, as we called out last quarter, we're expecting our margins this year to be higher than last year in the low eights, probably when you end up for the full year. Clearly, we had very strong margins in the first two quarters, but they taper down in Q4 typically. But we've got, as we'll get through later in the year, a line of sight into better margins going into next year, given some of the adjustments that we've called out. and then a path towards the 9% beyond that. We've had other elements affecting our margins as well, which is just the mix between our strong sales and our LCD business versus our specialty area. As that normalizes, you'll also see the improvement in our margins driven by that improved mix towards the FI segments.
spk02: Okay. I appreciate the time. Thank you.
spk04: Thanks, Michael.
spk01: And once again, ladies and gentlemen, if you would like to ask a question during this time, simply press star followed by the number one from your telephone keypad. To withdraw your question, press the pound or hash key. Your next question comes from the line of Steve Byrne with Bank of America. Steve, your line is open.
spk03: Yes, thank you. With respect to that 9% EBITDA margin target that you have, your ex-U.S. regions seem to already be well above that. It's your US region that is not. Is there something structural about that that enables the ex-US regions to have a higher EBITDA margin and perhaps highlight how you get there in the US market? What needs to happen?
spk05: Sure. Morning, Steve. And I think the big thing that's different between the U.S. and any other business that we have is its large, inorganic bulk business. And that tends to just drive the margin down a little bit. And so we have that large, inorganic business, which is very cash-generative, very profitable, but this tends to have a slightly lower margin than the business. And it's a bigger portion of our U.S. business compared to anywhere else on the planet. So I think we're very confident about our actions to streamline our processes, streamline our business, continue to enrich the mix, continue to drive specialty-focused industries. So I feel pretty confident about our ability to hit that 9% EBITDA margin run rate by the end of next year.
spk03: And I wanted to drill into the comment you made, David, on the win-loss ratio. I recall in years past, you argued that you were losing some of the new supply opportunities because you weren't pushing price. And I think you transformed the sales force to change that. What do you learn now from these cases? When you lose a new supplier opportunity, what would you attribute it to?
spk05: See, there isn't so much on supplier opportunities that we're losing. You know, we win those pretty consistently. And I think our specialty consumer solutions, industrial solutions team are very good at capturing those. And we have a number of those that we've spoken about. But the win-loss ratio speaks much more to customers, to customers winning and losing. So now we're winning more customers than we're losing. Some business will naturally churn. It's end of life. It's... A customer's maybe got a business. In the old days, we may have just lost them because they got fed up and went somewhere else. Now we're seeing more of them come back, more of them stick with us. We're seeing our digital tools helping us to have a better customer experience, a better buying experience. We talk about that effortless experience we think customers deserve. So we're very focused on delivering that so we can retain the base and add more business on top to really affect that win-loss ratio in a positive way and grow shares.
spk03: Thank you.
spk01: Your next question is a follow up question from the line of Michael McGinn with Wells Fargo. Michael, your line is open.
spk02: Hey, thanks, guys, for taking the follow up here. So I just wanted to Go back to the debt pay down. Can you just walk through some of the upside factors that would lead you to beat that target? And then maybe on the capital allocation side, what kind of synergistic opportunities here is there to add a bolt on an energy geography and kind of roll in some of the existing supply relationships you've had in other regions?
spk04: Yeah. So Michael, Nick, let me speak to the deleveraging. As you know, our original target was three times by the end of the year. We now have reduced that twice, looking to be at less than 2.7 times. Some of that's driven by the cash flow of the business, but also driven by the higher EBITDA. So generally, we're performing better than we thought starting out at the year. You know, in terms of upside opportunities, we continue to see good cash flow. There might be some additional divestiture realizations and also some of the timing of the capex changes. might impact that. But generally, we're on track to continue the lever, putting aside any future capital allocations. I'll let David speak to some of the synergistic M&A opportunities that we're looking into and pursuing and considering.
spk05: Yeah, thanks, Michael. I think that what we've built is a really good platform for growth. We have a good operating rhythm, we have a good sales structure, and we have a great now technology stack and digital platform, which gives us a really good infrastructure to plug new things into. So as well as globalizing our industrial solutions, consumer solutions businesses, so we have a consistent execution around the world, which has led to new supplier authorizations, not new new suppliers to Univar, but existing suppliers to Univar solutions, extending the reach into other markets. because we can offer this consistency of approach now and this digital infrastructure. It is very attractive to our suppliers to move with us. So we see really good opportunities now. We think we're a very good host for companies coming into us. We think we can really plug them into the infrastructure, into the network, and into the people network as well. to be able to make it an enjoyable experience now for any company that we happen to acquire and really drive accreted growth.
spk02: Great. And then just going back to the last question, you mentioned win-loss ratio. I'm just looking at the initiatives you have in place, ESG, new facilities, digital capabilities. When you say win-loss ratio, You know, are you benchmarking yourselves to the two big competitors that are out there, or is this just maybe a supplier decides to keep something internally? You know, for those solution-based sales where you're adding, you know, there's a value-add component, what's the lead time for winning business like that?
spk05: Okay, so there's a number of questions in that, Mike. But let's just go back to the win-loss ratio first of all. We don't benchmark that against anything other than ourselves. The question is, are we winning more business at a customer-skew combination level than we're losing? So this is, are we growing our customer-skew combinations? And how does that stack up year on year? So therefore, are we winning or losing the game? And we are winning the game. We are winning more than we're losing in terms of customer or business at that customer skew combination level. So we don't benchmark against anybody else, just ourselves. And that's a measure for us of are we winning or losing the battle? Are we winning share or not winning share? In terms of the dwell time or the lead time on some of the specialty sales, I mean, that can vary. That can vary in some of the, what I term, more fashion businesses, like food ingredients or beauty and personal care, where a new season will bring a new skin care, hair care, source food, whatever it may be. Now, that can be six months, nine months, On some of the other businesses, if I look at the pharma ingredients business or if I look at some of the industrial solutions business, the coatings business tends to be less fashion, less change. That can be more like 12 to 18 months. But we track all of those. We track everything through our development centers, our solution centers. So we know what the kind of average lead time is through our pipeline process. So that helps us to give a view of our forward opportunities
spk02: Great. Appreciate the time.
spk01: Ladies and gentlemen, that concludes our Q&A portion of the call today. And I'll turn the call over to Heather at this time.
spk00: Thank you, ladies and gentlemen, for your interest in Univar Solutions. Please be on the lookout for a save the date on our analyst day the next week. If you have any follow-up questions, please reach out to the investor relations team. This does conclude today's call.
spk01: Ladies and gentlemen, that concludes today's conference call. Thank you for participating. You may now disconnect.
Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-